Liquid Biopsy Versus Tissue Biopsy to Determine Front Line Therapy in Metastatic Non-Small Cell Lung Cancer (NSCLC) von Raez, Luis E., Brice, Kayla, Dumais, Katerine, Lopez-Cohen, Alejandro, Wietecha, Delia, Izquierdo, Paola A., Santos, Edgardo S., Powery, Hermán W.

Volltext

Outcomes of patients with unresectable stage III non-small cell lung cancer treated with durvalumab and subsequent therapies after disease progression von Dickson, Franco Adjei-Baffour, Raez, Luis E., Dumais, Katerine, Powery, Herman W., Walker, Damaal

Volltext

Clinical predictive markers of response to immune checkpoint inhibitor therapy in advanced non-small cell lung cancer von Rhone, Raena, Dumais, Katerine, Powery, Herman W., Gentile, Frank, Raez, Luis E.

Volltext

Serine/threonine kinase 11 (STK11) mutations and immunotherapy resistance in patients with non-small cell lung cancer von Uba, Richie, Raez, Luis E., Dumais, Katerine, Gentile, Frank, Powery, Herman W., Domingo, Gelenis Calzadilla, Izquierdo, Paola, Hunis, Brian

Volltext

Liquid biopsies for the front line therapy decision in non-small cell lung cancer von Brice, Kayla, Raez, Luis E., Dumais, Katerine, Wietecha, Delia, Lopez-Cohen, Alejandro, Izquierdo, Paola, Drusbosky, Leylah, Dada, Hiba I., Powery, Herman W.

Volltext

Lung cancer immunotherapy outcomes in Hispanic patients von Raez, Luis E., Munoz-Antonia, Teresita, Cress, W. Douglas, Hunis, Brian, Chiappori, Alberto, Dietrich, Martin, Antonia, Scott Joseph, Powery, Herman, Izquierdo, Paola, Sumarriva, Daniel

Volltext